HomeBiotech

Biotech

Biotech

Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer

Life Sciences Times - 0
Biotech

Alliance Foundation Trials and Natera Launch Phase III Breast Cancer Study

Life Sciences Times - 0
Biotech

Vyome Secures U.S. Patent Allowance for VT-1908 Ocular Inflammation Program

Life Sciences Times - 0
Biotech

Shift Bioscience Study Supports AI Virtual Cells for Drug Target Discovery

Life Sciences Times - 0
Biotech

Stoke Therapeutics Aligns With FDA on Planned Zorevunersen NDA

Life Sciences Times - 0
Biotech

Clear Scientific Reports Positive Phase 2 Results for Experimental Fentanyl Removal Treatment

Life Sciences Times - 0
Biotech

Verastem Reports New Data Supporting Avutometinib Plus Defactinib in Recurrent Ovarian Cancer

Life Sciences Times - 0
Biotech

Montai Therapeutics Begins Phase 1 Clinical Trial of Oral Drug for Ulcerative Colitis

Life Sciences Times - 0
Biotech

BostonGene Chief Medical Officer to Discuss AI and Multimodal Data in Cancer Drug Development

Life Sciences Times - 0
Biotech

Viome Acquires Sōlaria Biō to Expand Personalized Health and Medical Food Portfolio

Life Sciences Times - 0
Biotech

Q32 Bio Reports Phase 2a Bempikibart Results in Alopecia Areata

Life Sciences Times - 0
Biotech

Celea Therapeutics Details Phase 3 SURPASS-IPF Trial at IPF Summit 2026

Life Sciences Times - 0
123...117Page 2 of 117

Most Read